70
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Docetaxel
Docetaxel at starting dose of 65 mg/m2 IV on day 1 every 3 weeks for a total of 6 cycles
Pemetrexed
Pemetrexed at starting dose of 400 mg/m2 IV on day 1 every 3 weeks for a total of 6 cycles
University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli
"IASO General Hospital of Athnes, Dep of Medical Oncology", Athens
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
Air Forces Military Hospital, Dep of Medical Oncology, Athens
Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases, Athens
"Sotiria General Hospital, 1st Dep of Pulmonary Diseases", Athens
"Diabalkaniko Hospital of Thessaloniki", Thessaloniki
"Theagenion Anticancer Hospital of Thessaloniki", Thessaloniki
Lead Sponsor
University Hospital of Crete
OTHER
Hellenic Oncology Research Group
OTHER